157 related articles for article (PubMed ID: 6228193)
1. Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
Forward KR; Harding GK; Gray GJ; Urias BA; Ronald AR
Antimicrob Agents Chemother; 1983 Oct; 24(4):602-4. PubMed ID: 6228193
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
Downs J; Andriole VT; Ryan JL
Antimicrob Agents Chemother; 1982 Apr; 21(4):670-2. PubMed ID: 6211142
[TBL] [Abstract][Full Text] [Related]
3. In vitro antibacterial activity of norfloxacin (MK-0366).
King A; Warren C; Shannon K; Phillips I
Antimicrob Agents Chemother; 1982 Apr; 21(4):604-7. PubMed ID: 6211139
[TBL] [Abstract][Full Text] [Related]
4. Norfloxacin: in vitro activity compared with that of seven other antibacterial agents against urinary tract pathogens.
Digranes A; Dibb WL; Ostervold B
Acta Pathol Microbiol Immunol Scand B; 1984 Apr; 92(2):101-6. PubMed ID: 6233841
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
Wise R; Andrews JM; Edwards LJ
Antimicrob Agents Chemother; 1983 Apr; 23(4):559-64. PubMed ID: 6222695
[TBL] [Abstract][Full Text] [Related]
6. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
Tenney JH; Maack RW; Chippendale GR
Antimicrob Agents Chemother; 1983 Jan; 23(1):188-9. PubMed ID: 6219620
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
[TBL] [Abstract][Full Text] [Related]
8. Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
Shungu DL; Weinberg E; Gadebusch HH
Antimicrob Agents Chemother; 1983 Feb; 23(2):256-60. PubMed ID: 6220671
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
[TBL] [Abstract][Full Text] [Related]
10. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
11. Comparison of imipenem and five other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa.
Gerçeker AA; Otük G
Chemotherapy; 1995; 41(5):334-6. PubMed ID: 8521734
[TBL] [Abstract][Full Text] [Related]
12. In vitro emergence of Escherichia coli and Pseudomonas aeruginosa strains resistant to norfloxacin and nalidixic acid.
Piffaretti JC; Demarta A; Leidi-Bulla L; Peduzzi R
Eur J Clin Microbiol; 1983 Dec; 2(6):600-1. PubMed ID: 6230227
[No Abstract] [Full Text] [Related]
13. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of norfloxacin.
Norrby SR; Jonsson M
Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
[TBL] [Abstract][Full Text] [Related]
15. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of enoxacin compared with norfloxacin and amikacin.
van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the new 4-quinolone compound Ro 23-6240.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
Clarke AM; Zemcov SJ; Campbell ME
J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
Gadebusch HH; Shungu DL; Weinberg E; Chung SK
Infection; 1982 Jan; 10(1):41-4. PubMed ID: 6461606
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activity of AT-2266.
Kouno K; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1983 Jul; 24(1):78-84. PubMed ID: 6226242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
